EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
1,800,168
Share change
+1,246,881
Total reported value
$5,580,000
Price per share
$3.10
Number of holders
22
Value change
+$3,895,639
Number of buys
18
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q1 2017

As of 31 Mar 2017, EVOKE PHARMA INC - COM (EVOK) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,800,168 shares. The largest 10 holders included SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, STATE TREASURER STATE OF MICHIGAN, Knoll Capital Management, LP, Precept Management LLC, BlackRock Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Bank of New York Mellon Corp, Commonwealth Equity Services, Inc, and NORTHERN TRUST CORP. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.